An experienced corporate lawyer, Lis advises listed and private companies, multinationals, and not-for-profit organisations on their structure, governance, operations and strategy. Her clients appreciate her commitment to building long term relationships and understanding their culture and strategy so as to deliver timely, thoughtful and practical advice.
At a strategic level, Lis collaborates with boards and senior executives on significant transactions — such as capital raisings, restructuring, strategic collaborations and mergers and acquisitions (public and private). Lis’s deep experience and practical insights are particularly appreciated by growing clients who seek her guidance on how to plan and execute these important projects.
Lis also helps organisations review their governance framework so that it is “fit for purpose”, and provides emotionally intelligent advice on engaging with key stakeholders around complex member approvals, or dealing with conflicts of interest. In this, Lis brings additional perspectives as a graduate of the Australian Institute of Company Directors. For listed companies, Lis gives practical direction on meeting continuous disclosure obligations.
At an operational level, Lis guides clients in how to integrate business ethics and legal compliance into “business as usual”, training boards and managers on fulfilling their key legal obligations, such as privacy and directors’ & officers’ duties. Lis also designs contract review frameworks in line with the organisation’s risk appetite as well as drafting and negotiating complex contracts.
Lis’s strong focus on Life Sciences and Healthcare is reflected in her appointment as deputy chair of AusBiotech’s AusMedtech Advisory Group, and as a member of AusBiotech’s State Committee for NSW. Lis has also actively participated in AusBiotech industry projects including AusBiotech’s Guide for Directors of Life Sciences Companies, AusBiotech’s Guide for Investors in Life Sciences Companies and pitching workshops for Life Sciences CEOs. She enjoys being a “connector” between people in her network, to strengthen the Australian life sciences ecosystem.
‘Lis Boyce is very commercial, personally engaged, quick to call in further expertise from within the firm where required. Lis has been actively involved in our matters and has helped us resolve several difficult situations with investors relating to contract technicalities, debt and equity maturity, and conversion, adjustment of shareholdings, deal documentation.’
The Legal 500 Asia-Pacific: Corporate and M&A, 2021 edition – Testimonials
- Chambers and Partners Asia-Pacific – Life Sciences – Band 4 in 2021 edition
- Best Lawyers in Australia – Recognised for Life Sciences Practice (Sydney, AU) – since 2020 edition
- The Legal 500 Asia-Pacific – Recognised ‘Key Lawyer’ for Corporate and M&A – 2021 edition
Recent deals and media coverage
- Piper Alderman recruits health and life sciences partner – Lawyers Weekly, 31 January 2021
- Australian Institute of Company Directors (Graduate)
- Governance Institute of Australia (Fellow)
- Financial Services Institute of Australasia (Senior Fellow)
30 September 2021
COVID-19 testing at home: new regulation to allow rapid antigen self-testsRead More
30 August 2021